Calidi Biotherapeutics Advances Cancer Treatment Platform with Innovative Immunotherapy Approach
Calidi Biotherapeutics has developed a novel systemic antitumor virotherapy platform that delivers an IL15 superagonist directly into tumor microenvironments, potentially revolutionizing metastatic cancer treatment by boosting immune response while minimizing systemic toxicity.
